Find Academic Supervisors

• Maternal-Fetal Medicine
• Obstetric Ultrasound
• Fetal Development
• +3 more

Dr. Emily Lee serves as an Assistant Professor at Yale School of Medicine in the Department of Obstetrics, Gynecology & Reproductive Sciences, with a clinical focus in Maternal-Fetal Medicine. She completed her Maternal-Fetal Medicine fellowship at Yale in 2023 following her Obstetrics & Gynecology residency at UCLA. Dr. Lee earned her MD from the University of Michigan and completed her undergraduate studies at Yale University with a BA in Economics and Religious Studies. Dr. Lee's research primarily focuses on advancing fetal monitoring techniques, particularly in the areas of obstetric ultrasound and non-invasive fetal electroencephalography. Her work explores innovative approaches to prenatal diagnosis, fetal development assessment, and improving clinical outcomes in complex pregnancies including twin gestations. She has developed simulation-based educational programs for obstetric ultrasound training that enhance clinical skills for medical learners. Her recent publications demonstrate a strong emphasis on improving diagnostic accuracy in fetal cardiac assessment, understanding the implications of maternal obesity on prenatal procedures, and developing novel methods for non-invasive fetal neurological monitoring. Dr. Lee's research bridges clinical practice with technological innovation in maternal-fetal medicine. Among her notable recognitions are the prestigious 2024 Blavatnik Award and the Yale Innovation Summit Blavatnik Accelerator Award in 2023, highlighting her contributions to medical innovation. She has also received the Best Maternal-Fetal Medicine Oral Presentation award from the New England Perinatal Society in 2023, along with earlier recognition for her research at UCLA and international conferences. Dr. Lee actively contributes to medical education through her Point-of-Care Ultrasound Simulation Curriculum and regularly presents on topics including substance use in pregnancy, marijuana usage effects, and advanced fetal monitoring techniques. Her work with the Reproductive Sciences department at Yale focuses on translating research into clinical practice to improve maternal and fetal outcomes.

Anne G HoenView profile

Associate Professor

• Microbiome research
• Epidemiology
• Environmental health
• +7 more

Anne G Hoen is an Associate Professor at the Geisel School of Medicine , Dartmouth College, with joint appointments in Epidemiology , Biomedical Data Science , and Microbiology and Immunology . Her research focuses on microbiome development in infants, environmental exposures, and their associations with health outcomes, using interdisciplinary approaches including statistical modeling and bioinformatics. Research Interests: She explores how microbial communities in early life influence disease risk through environmental and dietary factors. Her work integrates microbiome-metabolome interactions, computational methods for microbial network analysis, and epidemiological studies of infectious diseases. Recent Article Trends: 2025-2024 publications highlight maternal diet-microbiome links, microbial interaction networks, ECHO consortium collaborations, and novel computational approaches for microbiome data. Key sub-fields include perinatal exposome, microRNA profiling, and longitudinal metabolomic analysis. Scientific Awards: K01LM011985: Bioinformatics strategies for early life microbiomics R01LM012723: Multi-omic functional integration using networks Advising: Mentors current PhD students in Dartmouth's Quantitative Biomedical Sciences (QBS) program, including Becky Lebeaux and Quang Nguyen, while alumni like Sara Lundgren and Wes Viles hold postdoctoral and academic positions.

Jashvant UnadkatView profile

Professor

• Pharmacokinetics
• Pharmacodynamics
• Drug Transporters
• +7 more

Jashvant Unadkat, Ph.D. is a Professor of Pharmaceutics at the University of Washington School of Pharmacy. He holds appointments in the Department of Pharmaceutics and is actively involved with the UWPKDAP (Program on Pharmacokinetics of Drugs of Abuse during Pregnancy). His research spans drug transport, metabolism, and pharmacokinetics with special emphasis on pregnancy and fetal pharmacology. Dr. Unadkat received his B.Pharm. from the University of London (1977), his Ph.D. from the University of Manchester (1982), and completed postdoctoral training at the University of California at San Francisco (1982-85). His educational background laid the foundation for his extensive career in pharmaceutical sciences. His research interests focus on mechanisms of drug transport and metabolism, particularly during pregnancy. Dr. Unadkat has made significant contributions to understanding placental drug transporters, blood-brain barrier function, and quantitative approaches to pharmacokinetics-pharmacodynamics. His work bridges computational modeling with experimental approaches to address complex questions in drug disposition. Analysis of his recent publications reveals a strong trend toward understanding drug interactions during pregnancy, cannabinoid pharmacology, and the application of physiologically based pharmacokinetic (PBPK) modeling to predict drug behavior in special populations. His research spans pharmacology, computational biology, obstetrics, and toxicology with particular emphasis on drug transporters and their regulation. Fellow of AAAS Fellow of AAPS Fellow of JSSX AAPS Research Achievement Award (2012) ISSX Research Achievement Award (2023) Founding co-chair (1999-2001) of AAPS focus group on Drug Transport and Uptake Dr. Unadkat has led significant research initiatives including the UW Research Affiliates Program on Transporters (UWRAPT) for 10 years, the NIDA-funded UWPKDAP program on drug disposition during pregnancy, and co-leads the NICHD-funded UW Transporter Elucidation Center. His work has generated over 250 peer-reviewed publications and has significantly influenced regulatory science and drug development practices. He is actively involved in research teams focusing on placental transport, hepatic drug metabolism, and quantitative pharmacology. His current work with the UW Transporter Elucidation Center aims to identify and characterize novel transporters in the placenta and developing intestine, with implications for drug safety during pregnancy and pediatric pharmacotherapy.

Sarah JonesView profile

Associate Professor

• Thrombosis
• Haemostasis
• Platelet Biology
• +3 more

Dr. Sarah Jones is an Associate Professor in Thrombosis and Haemostasis at Manchester Metropolitan University, serving as Deputy Director of Research for the Department of Life Sciences. She leads the Thrombosis Group and holds an honorary Reader position at the University of Manchester. Academic Affiliation: Manchester Metropolitan University Secondary Appointment: University of Manchester (Honorary Reader) Over 20 years, Dr. Jones has pioneered research on platelet signaling pathways and their role in thrombosis. Her current work focuses on platelet-endothelial crosstalk in disease states, with emphasis on in vitro thrombosis modeling to replace animal testing. This research, funded by BBSRC, NC3Rs, and BHF, addresses cardiovascular disease mechanisms and translational antithrombotic testing. Her scientific publications demonstrate expertise in platelet biology (Pim kinase signaling, SIRT1 regulation, proteoglycan interactions) and thrombosis modeling. Recent work includes placental perfusion studies for pregnancy-related cardiovascular complications. Grants & Projects: UKRI (NC3Rs) Partnership and Impact Award (2025-2026) UKRI BBSRC/NC3Rs grant for human haemostasis models (2023-2025) British Heart Foundation collaborations (2021-2025) Dr. Jones supervises PhD students (Mishaal Reyman, Poppy White, etc.) and teaches on Biomedical Science, Cellular Science, and Clinical Haematology programs. She has developed innovative endothelialised in-vitro thrombosis models that reduce animal usage in cardiovascular research.

Natalie D. EddingtonView profile

Professor

• Pharmacokinetics
• Drug Delivery Systems
• Biopharmaceutics
• +3 more

Dr. Natalie D. Eddington is Professor and Dean Emeritus at the University of Maryland School of Pharmacy, where she previously chaired the Department of Pharmaceutical Sciences. Her expertise spans pharmacokinetics, drug delivery, and regulatory science, with research focusing on optimizing drug therapy for cancer, epilepsy, and substance abuse disorders. Her laboratory investigates drug transport mechanisms (particularly P-glycoprotein), opioid pharmacokinetics, and maternal-fetal drug distribution. Seminal work includes characterization of Salvinorin A metabolism, P-gp regulation by hormones, and methadone's effects on drug-metabolizing enzymes. Her FDA-supported research on Scale-Up and Post Approval Changes (SUPAC) guidances significantly reduced regulatory burdens for pharmaceutical manufacturers. As dean, she established multiple research centers including the Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) and pioneered the School's pharmapreneurism initiative. An elected fellow of AAPS and ACCP, she has authored over 125 publications and developed international regulatory training programs.

Kimberly Keil StietzView profile

Assistant Professor

• Environmental Toxicology
• Neurotoxicology
• Urology
• +4 more

Kimberly Keil Stietz is an Assistant Professor in the Department of Comparative Biosciences at the University of Wisconsin-Madison School of Veterinary Medicine. Her research focuses on environmental toxicology, neurotoxicology, and urology, particularly examining how developmental exposure to polychlorinated biphenyls (PCBs) affects urinary function. Education: B.S. in Biology, St. Norbert College (2010) Ph.D. in Comparative Biosciences, University of Wisconsin-Madison (2014) Postdoctoral research in neurotoxicology, University of California-Davis (2015-2019) Stietz's lab investigates the effects of environmental contaminants on the lower urinary tract, emphasizing PCB exposure during development. Using in vitro and in vivo mouse models, the lab studies disruptions in bladder epithelium organization, nerve fiber patterning, inflammation, and peripheral-central nervous system crosstalk. Key projects include analyzing PCB impacts on bladder barrier function, innervation patterns, inflammatory responses, and dorsal root ganglia signaling. Recent publications highlight her work on PCB effects across multiple domains: adult female bladder contractility (2023), prostatic collagen changes (2023), machine learning-aided metabolite analysis (2023, 2022), and developmental PCB exposure links to voiding physiology (2022). Her 2021 studies explored behavioral phenotypes in PCB-exposed mice, dendritic effects, and bladder inflammation, while 2019 work included host-microbe interactions and open-source uroflowmetry tools.

James LacefieldView profile

Professor

• Biomedical Ultrasound Imaging
• Vascular Imaging
• Cancer Research Applications
• +5 more

James Lacefield is a Professor in both the Department of Electrical and Computer Engineering and the Department of Medical Biophysics at Western University. He serves as Director of the School of Biomedical Engineering and maintains his research laboratory in the Amit Chakma Engineering Building. His academic appointments span multiple disciplines, reflecting the interdisciplinary nature of his work in biomedical ultrasound imaging. Dr. Lacefield earned his Ph.D. and B.S.E. in Biomedical Engineering from Duke University. His educational background established the foundation for his current research program that bridges engineering principles with medical applications. His research focuses on the physical acoustics and signal processing aspects of ultrasound imaging, with particular emphasis on quantitative vascular imaging applications. Dr. Lacefield's laboratory develops novel methods for color Doppler, power Doppler, and contrast-enhanced ultrasound imaging, with primary applications in cancer research. Current projects include optimization of high-resolution ultrasound systems for tumor vascular characterization and development of methods to quantify spatial blood flow distribution in tumors. Analysis of his recent publications reveals a strong focus on quantitative ultrasound techniques for cancer applications, with particular attention to tumor perfusion assessment using contrast-enhanced ultrasound. His work demonstrates increasing sophistication in speckle analysis methods to improve the reliability of perfusion measurements in preclinical tumor models. Associate Editor, IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control Member, Council of Chairs of Bioengineering and Biomedical Engineering Member, College of Reviewers, Canadian Institutes of Health Research Dr. Lacefield maintains active collaborations with multiple research groups including the Imaging Research Laboratories at Robarts Research Institute. His professional activities include editorial work for major ultrasound journals and participation in national review panels for biomedical research funding.

• Transplantation Immunology
• Immunological Tolerance
• Humoral Immunity
• +7 more

Professor Anita Chong is a distinguished immunologist at the University of Chicago's Pritzker School of Medicine, Department of Surgery-Transplant, where she leads groundbreaking research in transplantation immunology and tolerance mechanisms. Her laboratory has established herself as a leading authority in understanding the complex interplay between the immune system and organ transplantation. Dr. Chong's educational background includes a BS (Hons) from the University of Malaya, Malaysia, a PhD from Australian National University, Australia, and postdoctoral training at Tufts University, Boston, MA, followed by research associate work at the University of Arizona, Tucson, AZ. Her research program focuses on immunological tolerance and humoral immunity following allogeneic transplantation, with particular emphasis on understanding how infections prevent the induction of transplantation tolerance or destabilize established tolerance. Dr. Chong has developed innovative approaches to track defined populations of endogenous allospecific T cells (including CD4+ effectors, CD4+ Tregs, and CD8 effectors) and B cells, examining their behavior under conditions of rejection, memory/sensitization, and tolerance. She actively investigates memory alloreactive B cells in transplantation settings and has expanded her research into vaccination strategies to prevent infections as a means of stabilizing tolerance. Analysis of Dr. Chong's recent publications reveals a strong focus on cellular mechanisms of transplant tolerance and rejection, with particular emphasis on B cell biology, T regulatory cells, and the impact of infections on transplant outcomes. Her work increasingly incorporates multi-omics approaches and examines sex and gender differences in transplant outcomes, reflecting evolving trends in precision medicine within transplantation. Dr. Chong serves as Principal Investigator on multiple significant NIH-funded research projects, including R01AI182097 (Mechanistic studies on pregnancy-induced humoral sensitization in organ transplantation), R01AI148705 (Intrarenal B cells in acute kidney allograft rejection), and R01AI142747 (Deconstructing B cell transplantation tolerance). She has also served as Co-Principal Investigator on numerous collaborative grants. Her laboratory maintains extensive collaborations with Dr. Marisa Alegre studying infections and transplantation tolerance, Dr. Roger Sciammas at UC Davis, clinical transplant faculty at the University of Chicago and Ohio State University, Dr. Chris Montgomery on vaccination research, and Dr. Joel Collier at Duke University developing nanoparticulate adjuvant-free vaccines. These collaborative efforts have positioned her laboratory at the forefront of translational transplantation research with significant implications for clinical practice.

• Cerebral Microcirculation
• Vascular Biology
• Endothelial Cell Function
• +6 more

William Mayhan is a Professor in Biomedical Sciences at the University of South Dakota . His research focuses on cerebral microcirculation and vascular biology , particularly examining endothelial cell function in disease states like diabetes and alcohol consumption. Education: PhD in Biomedical Sciences, University of Nebraska Medical Center (1983) Post-Doctoral Fellowship, University of Iowa (1985) BS in Biology, Creighton University (1977) His work investigates blood-brain barrier permeability and cerebral vasculature responses to hypertension, diabetes, and alcohol. Key findings include mechanisms of nitric oxide synthase (NOS) dysfunction and oxidative stress in diabetic and alcoholic models. Recent publications analyze prenatal alcohol exposure effects on cerebral arterioles and CB2 receptor agonists for vascular protection in diabetes. His studies span in vivo models, potassium channel dynamics , and inflammatory mediators in stroke pathogenesis.

Dave BridgesView profile

Associate Professor

• Nutrient sensing
• Cellular signaling
• Metabolic regulation
• +7 more

Dr. Dave Bridges is an Associate Professor in the Department of Nutritional Sciences at the University of Michigan School of Public Health . Trained as a molecular biologist and biochemist, his research focuses on the regulation of macronutrient metabolism with emphasis on obesity, diabetes, and cardiovascular disease. The Bridges Lab employs Drosophila , mouse, and human clinical models to investigate nutrient sensing pathways like mTORC1, glucocorticoid signaling, and precision nutrition approaches. Education: PhD, University of Calgary (2005) BS, University of Calgary (2000) Research areas include nutrient signaling pathways , stress-hormone interactions , and precision nutrition through ketogenic diet studies. Collaborations with Dr. Brigid Gregg examine breastmilk lipid variability and maternal health impacts. Recent work explores Bayesian statistical approaches for nutritional research, advocating for brms package implementation. Contact: Email: davebrid@umich.edu Phone: 734-764-1266 Address: 1415 Washington Heights, Ann Arbor, MI 48109

• Anthropology
• Global Public Health
• Mental Health
• +4 more

Catherine Panter-Brick is the Bruce A. and Davi-Ellen Chabner Professor of Anthropology, Health, and Global Affairs at Yale University, with appointments at the Jackson School of Global Affairs and Department of Anthropology. She directs the Global Health Studies Multidisciplinary Academic Program and the Program on Conflict, Resilience, and Health, focusing on biocultural analyses of adversity, resilience, and peacebuilding. Key affiliations: Yale Institute for Global Health, Social and Behavioral Sciences, African Studies, South Asian Studies Her research examines: Health impacts of poverty, armed conflict, and social marginalization Intergenerational trauma and epigenetic signatures Refugee mental health and psychosocial interventions Gender roles in post-conflict recovery Systems-level approaches to peacebuilding Publications since 2022 demonstrate sustained focus on: Conflict-related stress biomarkers (cortisol, telomere length) Community-based mental health programs for refugees Cultural dimensions of resilience and wellbeing Humanitarian policy innovation and science diplomacy Scientific Recognition: Lucy Mair Medal (2011) for anthropological applications to poverty alleviation Keynote speaker at UN, WHO, and World Bank As Senior Editor of Social Science & Medicine 's Medical Anthropology section, she bridges academic research with policy implementation through fieldwork in Afghanistan, Syria, Jordan, and Brazil.

• Autism Spectrum Disorder
• Biostatistical Methods
• Chronic disease
• +4 more

Xiaoyu Che is an Assistant Professor of Biostatistics at Columbia University's Mailman School of Public Health, where he serves as the principal biostatistician in the Center for Infection and Immunity (CII) at Columbia University Irving Medical Center. His work bridges statistical methodology with biomedical research, focusing on complex disease mechanisms through advanced data analysis approaches. Dr. Che received his academic training at prestigious institutions: BS in Mathematics from Zhejiang University (2006) PhD in Mathematics from Claremont Graduate University (2013) Dr. Che's research program centers on the development and application of statistical methods for multi-omics analyses, with particular focus on understanding the pathogenesis of chronic and neurodevelopmental conditions. His work spans multiple domains including Autism Spectrum Disorder (ASD), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), and Gulf War Illness (GWI). He employs sophisticated biostatistical approaches to integrate diverse biological data types, revealing novel insights into disease mechanisms. His methodological expertise includes Bayesian statistics, metabolomic analysis, immune signature identification, and microbiome characterization, all aimed at translating complex biological data into meaningful clinical insights. Analysis of Dr. Che's publication record reveals a strong thematic focus on applying advanced statistical methods to understand complex disease mechanisms. His work consistently bridges biostatistical innovation with biomedical discovery, particularly in the areas of neurodevelopmental disorders and chronic fatigue conditions. The publications demonstrate progression from foundational methodological work to increasingly sophisticated multi-omics integration approaches, reflecting both technical growth and expanding research impact. His collaborative approach is evident through numerous high-impact publications with interdisciplinary teams across Columbia University and beyond. Dr. Che teaches BIST P8104: Probability in the Biostatistics MS degree program at Columbia, demonstrating his commitment to training the next generation of biostatisticians. While specific grant information isn't detailed in the provided materials, his extensive publication record across multiple high-impact journals suggests successful grant funding supporting his research program. As principal biostatistician in the Center for Infection and Immunity, Dr. Che plays a critical role in the analytical framework of the center's research initiatives. His work supports the center's mission to understand the relationship between infectious agents and human health through rigorous quantitative analysis. The collaborative nature of his research is evident in the diverse range of co-authors spanning immunology, virology, microbiology, and clinical medicine.

Olof StephanssonView profile

Researcher

• Reproductive Epidemiology
• Perinatal Health
• Maternal Obesity
• +4 more

Olof Stephansson is a senior researcher and group leader at the Clinical Epidemiology Unit (KEP) , Karolinska Institutet , focusing on reproductive, perinatal, and pediatric epidemiology. His work utilizes Swedish healthcare registries and quality registers to investigate risk factors, interventions, and medical management during pregnancy and childbirth. Key research areas: maternal obesity, preeclampsia prediction, climate change impacts, neonatal neurodevelopment, IBD in pregnancy, and labor management Funded by: Swedish Research Council, NIH, FORTE, NordForsk, and Karolinska Institute Collaborates with: Stanford, Oregon Health, University of British Columbia, London School of Hygiene, University of Witwatersrand His group (2014-present) manages the Swedish Pregnancy Registry and conducts randomized trials like the Oneplus study on midwifery models. Recent publications (2024-2025) analyze maternal BMI effects on offspring sleep, labor duration risks, and vaccine safety in pregnancy.

Andrea H. BrandView profile

Professor

• Stem Cell Biology
• Neuroscience
• Developmental Biology
• +3 more

Andrea H. Brand serves as the Frederick L. Ehrman Professor of Cell Biology and Professor of Neuroscience at NYU Grossman School of Medicine, New York University, where she chairs the Department of Cell Biology. Her dual appointments reflect an interdisciplinary research program spanning molecular mechanisms of stem cell regulation and neural development. Dr. Brand earned her PhD from the University of Cambridge followed by prestigious postdoctoral fellowships: a Leukemia Society Special Fellowship at Harvard Medical School and a Helen Hay Whitney Fellowship at Harvard University. These foundational experiences established her expertise in genetic model systems. Her research integrates stem cell biology and neuroscience through innovative work with Drosophila and mouse models. Key investigations focus on chromatin dynamics in stem cell quiescence, Notch/insulin signaling pathways, neural progenitor reprogramming, and blood-brain barrier formation. Current projects explore obesity-related gene function and CHD8 genomic targets relevant to neurodevelopmental disorders, emphasizing translational potential for regenerative medicine. Recent publications (2020-2022) reveal consistent themes in stem cell niche organization and disease mechanisms, with notable contributions to understanding tumorigenesis through neural progenitor studies and metabolic influences on barrier development. Her work demonstrates strong interdisciplinary convergence between developmental genetics and systems neuroscience. No scientific awards were documented in the provided profile information. While the profile indicates Professor Brand's leadership as Department Chair, specific details regarding student mentorship, grant funding, or laboratory structure were not included in the available text. Her position suggests active supervision of research teams and potential involvement in major collaborative initiatives.

• Child Psychiatry
• Family Therapy
• Mentalization-Based Treatment
• +3 more

Line Brotnow Decker is a Lecturer in the Child Study Center at Yale School of Medicine. She holds a BS in Psychology from Université de Paris (2011) and an MSc in Developmental Neuroscience and Psychopathology from University College London (2013). Her research focuses on intensive home-based treatments for youth with psychiatric conditions, family systems therapy, maternal mental health, and behavioral motivation measurement. Dr. Decker co-developed the CRAVE Scale for assessing motivation states related to physical activity and has published extensively on interventions targeting high-risk youth, parent-clinician collaboration, and prenatal stress impacts. Key Research Areas: Mentalization-based interventions, family therapy, school absenteeism interventions, and maternal-child health dynamics Notable Contributions: Evaluation of IICAPS home-based program, development of CRAVE Scale, studies on parent-clinician disagreement impacts Her work emphasizes practical clinical strategies for improving family mental health treatment outcomes through enhanced clinician-parent collaboration and tailored behavioral interventions. Dr. Decker collaborates with institutions like the Stephen & Denise Adams Center for Parkinson’s Disease Research on translational child psychiatry initiatives.